Caldera Health Limited - Product Pipeline Analysis, 2013 Update - New Market Study Published

From: Fast Market Research, Inc.
Published: Fri Dec 06 2013

Caldera Health Limited (Caldera) is a molecular in vitro diagnostics company. The company develops diagnostic devices for the detection of early stage prostate cancer. Its product technologies include proscanZ, guardianZ and auditor. Caldera's ProscaNZ is a blood test for prostate cancer which extends the diagnostic range of the current PSA test. The company's ProstScreen is a gene-based device to decide between indolent and rapidly progressive cancers and undertake treatment by use of urine samples, plasma, circulating and biopsy tissues. It develops diagnostics based on the footprint technology which selects three layers of biomarkers for prostate cancer, expressed RNA, and secreted proteins from these expressed RNA, and antibodies to secreted proteins for diagnosis. Caldera is headquartered in Auckland, New Zealand.

Full Report Details at

This report is a source for data, analysis and actionable intelligence on the Caldera Health Limited portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.


* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Roche Diagnostics Limited - Product Pipeline Analysis, 2013 Update
- SANUWAVE Health, Inc. (SNWV) - Product Pipeline Analysis, 2013 Update
- OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2013 Update
- Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2013 Update
- GeneNews Limited (GEN) - Product Pipeline Analysis, 2013 Update
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »